Clinical trial

Breast Cancer Index (BCI) Registry

NCT04875351

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2021-04-14

PhaseN/A

Study timeline

Study start (actual)2021-04-14Date precision: day

Registry last updated2024-09-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit TestDIAGNOSTIC_TEST

Sponsors & collaborators

Biotheranostics, Inc.lead sponsor

Mapped research locations

DallasTexas, United States5 San AntonioTexas, United States4 MobileAlabama, United States3 El PasoTexas, United States3 HoustonTexas, United States2 PhoenixArizona, United States2 DenverColorado, United States2 AlbanyNew York, United States2 PhiladelphiaPennsylvania, United States1 AuroraColorado, United States1 BethesdaMaryland, United States1 ScottsdaleArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04875351 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.